Thiols provide the major intracellular redox milieu and can undergo reversible oxidation and reduction. To understand the role of thiols in redox signaling events, we have studied the effect of N-ethylmaleimide, a specific thiol alkylating agent, on platelet-derived growth factor-BB (PDGF-BB)-induced mitogenesis in vascular smooth muscle cells (VSMC). Thiol alkylation inhibited PDGF-BB-induced expression of the Fos and Jun family proteins and AP-1 activity in VSMC. Thiol alkylation also inhibited PDGF-BB-induced expression of cyclin A and growth in these cells. In contrast, thiol alkylation enhanced and sustained the effect of PDGF-BB on the activation of the Jak STAT pathway, and this event was correlated with inhibition of protein tyrosine phosphatase lB activity. Thiol alkylation via inducing the expression of p21 waf1/cip1 in a STAT1-and p53-dependent manner antagonized the downregulation of this cell cycle inhibitory molecule by PDGF-BB. The inhibition of AP-1 and activation of STATs, particularly STAT1, by thiol alkylation correlated with increased production of active caspase 1 and apoptosis in VSMC. Together, these findings suggest a role for thiols in mediating mitogenic and/or apoptotic signaling events in VSMC. These results also show that a sustained change in the intracellular thiol redox state can convert a mitogen into a death promoter.
Introduction
The redox state plays a critical role in the regulation of gene expression in prokaryotes and eukaryotes (Storz et al., 1990; Sen and Packer, 1996; Sun and Oberley, 1996; Zheng et al., 1998) . The supporting observations for the role of the redox state in the regulation of gene expression are listed as follows: (1) Oxidants regulate the activities of several transcription factors, including activator protein 1 (AP-1), nuclear factor kappa B (NFkB) and p53 (Schreck et al., 1991; Xanthoudakis et al., 1992; Chandel et al., 2000) . (2) Oxidants activate many signaling events, including stimulation of tyrosine phosphorylation of receptor and nonreceptor tyrosine kinases, activation of mitogen-activated protein kinases and induction of expression of proto-oncogenes (Rao et al., 1993a, b; Guyton et al., 1996; Knebel et al., 1996; Rao, 1996) . (3) Acute production of oxidants in response to various agonists, including growth factors and cytokines, has been reported in several cell types (Meier et al., 1989; Bae et al., 1997) , and their participation in the mitogenic effects of growth factors has also been demonstrated (Sundaresan et al., 1995; Rao et al., 1999) . (4) The presence of oxidant-generating systems such as NADH/NADPH-like oxidase in nonphagocytic cells has been reported (Krieger-Brauer and Kather, 1992) . (5) Cells also possess a variety of enzymatic and nonenzymatic mechanisms for rapid removal of, and protection from, oxidants (Meister and Anderson, 1983; Kang et al., 1998) . The latter two features also attest to the role of reactive oxygen species (ROS) as second messenger molecules in the signal transduction pathways (Schmidt et al., 1996) . Despite the growing body of information on redox regulation of gene expression, the molecules that are susceptible for agonist-induced reversible oxidation/reduction and the mechanisms of their involvement in the mediation of extracellular signals from the plasma membrane to the nucleus are largely unclear.
Protein and nonprotein thiols play an important role in the structure and function of many enzymes, transcription factors and transporters by virtue of their ability to undergo reversible oxidation and reduction (Zheng et al., 1998; Hoshi and Heinemann, 2001; Kuge et al., 2001) . In addition, the presence of several enzymatic mechanisms for the regeneration of thiols from their oxidized state has been reported in various cell types (Aslund et al., 1997; Stewart et al., 1998) . Oxidation of cysteinyl thiols in the active site of protein tyrosine phosphatase IB (PTPIB) has been observed as a mechanism of its reversible oxidation in response to growth factors and oxidants facilitating tyrosine phosphorylation and activation of receptor tyrosine kinases (Lee et al., 1998; Mahadev et al., 2001) . Furthermore, the depletion of cellular thiols causes oxidative stress, which is implicated in the pathogenesis of several diseases, including cancer and atherosclerosis, and in aging (Ames et al., 1993; Stadtman, 2001) . Based on this information, we hypothesize that thiols play a critical role in transmitting agonist-induced redox-sensitive mitogenic and apoptotic signals from the plasma membrane to the nucleus, leading to the induction of expression of specific target genes. If thiols play an important role in the signal transduction pathways, one would expect that blockade of these inorganic sulfur groups should affect signaling events either positively or negatively. We have studied the effect of N-ethylmaleimide (NEM), a specific thiol alkylating agent (Aghdasi et al., 1997; Clottes and Burchell, 1998; Kwaw et al., 2001) , on platelet-derived growth factor-BB (PDGF-BB)-induced mitogenesis in vascular smooth muscle cells (VSMC). Here, we report the following observations: (1) Thiol alkylation inhibits the AP-1 activity and growth induced by PDGF-BB. (2) In contrast, thiol alkylation enhances and sustains the effect of PDGF-BB on the activation of the Jak-STAT pathway, and this event correlates with inhibition of PTP1B activity. (3) Thiol alkylation via stimulating p53 activity and inducing the expression of p21 waf1/cip1 antagonizes the downregulation of the levels and/or activities of these molecules by PDGF-BB. (4) The inhibition of AP-1 and activation of p53 by thiol alkylation results in increased production of active caspase 1 and apoptosis. Thus, these findings provide evidence of a role of thiols in the signaling events of mitogenesis and apoptosis. These results also suggest that the mitogenic and/or the apoptotic responsiveness of the cell depends on its thiol redox state.
Results

Thiol alkylation inhibits PDGF-BB-induced AP-1 activity
To understand the role of thiols in redox signaling events, we have studied the effect of NEM, a thiol alkylating agent, on the mitogenic responses of PDGF-BB in VSMC. NEM has been used extensively in the characterization of functional sulfhydryls in a variety of proteins, including ion channels and enzymes (Aghdasi et al., 1997; Clottes and Burchell, 1998; Kwaw et al., 2001) . To determine thiol alkylation by NEM, growtharrested VSMC were treated with and without NEM (20 mm) for 30 min and free thiols were measured using DTNB reagent (Ellman, 1959) . NEM (20 mm) alkylated 65% of the available thiols in VSMC (control, 522711 nmole/mg protein vs NEM treatment, 21374 nmole/mg protein). The Fos and Jun family proto-oncogenes play an important role in cell growth and apoptosis (Shaulian and Karin, 2001) . Therefore, we first studied the effect of NEM on PDGF-BBinduced expression of the Fos and Jun family proteins. Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 5 min to 2 h and cell extracts were prepared. Cell extracts were analyzed by Western blotting for the Fos and Jun family proteins. PDGF-BB induced expression of c-Fos, Fos-B, Fra-1, c-Jun and Jun-B by 50-1000-fold as compared to their control levels ( Figure 1a) . NEM completely inhibited the PDGF-BB-induced expression of these proto-oncogenes. A significant amount of Jun-D was present in growth-arrested VSMC, and this level was not affected by either PDGF-BB or NEM treatment, alone or in concert. Fos and Jun proteins form the transcription factor AP-1 (Shaulian and Karin, 2001) . Since NEM inhibited the PDGF-BB-induced expression of the Fos and Jun family proteins, we next studied the effect of (a) Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times and cell lysates were prepared. A total of 40 mg of protein from control and each treatment was analyzed by Western blotting for the Fos and Jun family proteins using their specific antibodies. (b) Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times and nuclear extracts were prepared. A total of 5 mg of nuclear protein from control and each treatment was incubated with 100 000 c.p.m. of [ 32 p]-labeled AP-1 consensus oligonucleotide probe and the protein-DNA complexes were separated by electrophoresis on polyacrylamide gel. (c) VSMC that were transfected with an AP-1 promoter-dependent reporter plasmid, pCOLL-CAT, were growth-arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicted times and cell lysates were prepared. Cell lysates containing equal amounts of protein from control and each treatment were analyzed for CAT activity using [
14 C]-chloramphenicol and acetyl coenzyme A as substrates. The substrate and products were extracted with ethyl acetate, separated by TLC and subjected to autoradiography Sustained activation of STATs causes apoptosis in VSMC M Bhanoori et al NEM on PDGF-BB-induced AP-1 activity. Growtharrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 or 4 h, and nuclear extracts were prepared. Equal amounts of nuclear protein from control and each treatment were analyzed by EMSA for AP-l-DNA binding activity using [
32 P]-labeled AP-1 consensus oligonucleotide probe. PDGF-BB increased AP-l-DNA binding activity by 20-fold compared to control, and NEM completely blocked this effect (Figure 1b) . To learn whether thiol alkylation also inhibits PDGF-BBinduced AP-1-dependent transcription, VSMC were transfected with pCOLL-CAT plasmid, in which the transcription of CAT is controlled by a collagenase promoter containing a single AP-1 site, growth-arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 or 4 h, and cell extracts were prepared. Cell extracts containing an equal amount of protein from control and each treatment were assayed for CAT activity. Consistent with its effect on AP-l-DNA binding activity, PDGF-BB increased AP-1-dependent CAT expression by about 15-fold and this effect was completely inhibited by NEM (Figure 1c ). AP-1 plays an important role in cell proliferation (Shaulian and Karin, 2001) . To determine whether the inhibition of PDGF-BB-induced AP-1 activity by NEM has any influence on growth, quiescent VSMC were treated with and without PDGF-BB 
Thiol alkylation enhances PDGF-BB-stimulated tyrosine phosphorylation of PDGFRb
It is likely that the observed effects of NEM on PDGF-BB-induced AP-1 activity and growth are secondary to its alkylation of cysteinyl residues that are essential for the catalytic activities of various enzymes, transcription factors and/or transporters. Several studies have reported that protein tyrosine phosphatases (PTPases) contain critical cysteinyl residues in their catalytic motifs, and oxidation of these cysteinyl residues leads to their inactivation (Knebel et al., 1996; Denu and Dixon, 1998; Lee et al., 1998; Mahadev et al., 2001) . In view of these observations, it is possible that thiol alkylation shifts the balance between protein tyrosine phosphatases and protein tyrosine kinases towards the latter and thereby influences protein tyrosine phosphorylation events. Therefore, we decided to study the effect of thiol alkylation on PDGF-BB-induced protein tyrosine phosphorylation. Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 5 or 30 min, and cell extracts were prepared. Cell extracts containing an equal amount of protein from control and each treatment were analyzed by Western blotting for tyrosine phosphorylated proteins using anti-PY20 antibodies. PDGF-BB increased tyrosine phosphorylation of several proteins, with molecular masses ranging from 14 to 200 kDa. A four-fold increase in protein tyrosine phosphorylation was observed at 5 min of PDGF-BB treatment and these increases were sustained until 30 min of treatment (Figure 3a) . Thiol alkylation significantly enhanced PDGF-BB-stimulated protein tyrosine phosphorylation. Thiol alkylation alone had no significant effect on protein tyrosine phosphorylation. To identify some of the proteins that showed enhanced tyrosine phosphorylation by PDGF-BB in the presence of NEM, equal amounts of protein from control and each treatment were immunoprecipitated with anti-PDGF receptor b (PDGFRb) antibodies and the resulting immunocomplexes were analyzed by Western blotting using anti-PY20 antibodies. Tyrosine phosphorylation of a band with a molecular mass of 170 kDa was significantly increased in response to PDGF-BB. NEM enhanced PDGF-BB-induced tyrosine phosphorylation of this protein by about three-fold (Figure 3b ). Reprobing this blot with anti-PDGFRb antibodies also revealed a band of 170 kDa, suggesting that the identity of the tyrosine phosphorylated protein is PDGFRb. To learn whether thiol alkylation also modulates tyrosine phosphorylation of nonreceptor proteins, such as nonreceptor tyrosine kinases (NRTKs), we determined the tyrosine phosphorylation state of Jaks.
Extracts from VSMC treated as described in Figure 1 were analyzed by Western blotting for tyrosine phosphorylation of Jak1 and Jak2 using their phosphospecific antibodies. PDGF-BB stimulated tyrosine phosphorylation of both Jak1 and Jak2 in a timedependent manner, with a maximum 2-to 10-fold effect at 5 min for Jak2 and at 30 min for Jak1 and declining thereafter to almost basal levels by 2 h (Figure 4a ). Jak2 was more responsive to activation by PDGF-BB than Jak1. NEM enhanced the PDGF-BB-induced tyrosine phosphorylation of both Jak1 and Jak2. Treatment with NEM alone, while having no effect on Jak2 tyrosine phosphorylation, caused a modest increase in tyrosine phosphorylation of Jak1. Jaks catalyze tyrosine phosphorylation of STATs, leading to their activation (Darnell et al., 1994; Horvath et al., 1995) . To learn whether the increases in tyrosine phosphorylation of Jak1 and Jak2 result in increased tyrosine phosphorylation of their substrates, extracts from VSMC of control and each treatment were analyzed by Western blotting for tyrosine phosphorylation of STAT1, STAT3 and STAT5 using their phosphospecific antibodies. PDGF-BB increased tyrosine phosphorylation of all three STAT proteins in a time-dependent manner ( Figure 4b ). PDGF-BB-induced tyrosine phosphorylation of all three STATs peaked (5-to 10-fold) at 5 min and returned almost to basal levels by 2 h (Figure 4b ). NEM enhanced the PDGF-BB-induced tyrosine phosphorylation of all three STATs so that the increased phosphorylation states were sustained for at least 2 h of PDGF-BB treatment. NEM alone, while having no effect on STAT3 tyrosine phosphorylation, caused a modest increase in tyrosine phosphorylation of STAT1 and STAT5. To investigate whether the increases in tyrosine phosphorylation of STATs lead to their activation, STAT-DNA binding activities were measured. Equal amounts of nuclear protein isolated from VSMC that were treated with PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 h, or left untreated, were assayed for STAT-DNA binding activity by EMSA using [ To determine whether the increases in STAT-DNA binding activities were followed by corresponding increases in STAT-dependent transcription, VSMC were transfected with a STAT promoter-dependent CAT reporter gene plasmid, pSIE-CAT, growth-arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 6 h, and cell extracts prepared. Cell extracts containing equal amounts of protein from control and each treatment were assayed for CAT activity. PDGF-BB while alone induced STAT-dependent CAT transcription to some extent (1.5-fold); in the presence of NEM, this response was increased five-fold ( Figure 5b ). NEM alone also increased STAT-dependent CAT transcription.
Thiol alkylation inhibits PDGF-BB-induced PTP1B activity
To learn the possible mechanism by which NEMenhanced and sustained PDGF-BB-induced tyrosine phosphorylation of STATs, the role of PTP1B was tested. Incubation of VSMC with [
3 H]-NEM resulted in Figure 4 Effect of thiol alkylation on PDGF-BB-induced tyrosine phosphorylation of Jaks and STATs. Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times and cell lysates were prepared. An equal amount of protein from control and each treatment was analyzed by Western blotting for tyrosine phosphorylation of Jak1, Jak2, STAT1, STAT3 and STAT5 using their phosphospecific antibodies. pJak1, phospho-Jak1; pJak2, phosphoJak2; pSTAT1, phospho-STAT1; pSTAT3, phospho-STAT3; pSTAT5, phospho-STAT5
Sustained activation of STATs causes apoptosis in VSMC M Bhanoori et al labeling of PTP1B in a NAC-sensitive manner (NEM, 69 01174898 cpm/dish vs NAC+NEM 36607681 cpm/ dish), suggesting its thiol alkylation. To test the effect of thiol alkylation on its activity, an equal amount of protein from VSMC that were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) was immunoprecipitated with anti-PTP 1B antibodies and the phosphatase activity in the immunocomplexes was determined using p-nitrophenyl phosphate as a substrate. PDGF-BB stimulated PTP1B VSMC that were transfected with STAT promoter-dependent reporter plasmid, pSIE-CAT, were growtharrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 6 h and cell lysates were prepared. Cell lysates normalized for protein were assayed for CAT activity as described in the legend to Figure 1 Sustained activation of STATs causes apoptosis in VSMC M Bhanoori et al activity at 2 h by about two-fold and this was inhibited by NEM (Figure 6a ). At earlier time points of PDGF-BB treatment of VSMC, no significant changes were observed in PTP1B activity (data not shown). The time course of PDGF-BB-induced PTP1B activity correlated with the time course of dephosphorylation of STATs. The inhibition of PTP1B activity in the presence of NEM, therefore, appeared to be the likely mechanism involved in NEM-enhanced and -sustained PDGF-BBinduced phosphorylation of STATs. If this was true, then overexpression of wild-type PTP1B should reduce NEM-enhanced and -sustained PDGF-BB-induced phosphorylation of STATs. To test this, VSMC were infected with mock (EGFP) or PTP1B carrying adenovirus at a multiplicity of index (m.o.i.) of 10, growth arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 h and analyzed for tyrosine phosphorylation of STATs. VSMC infected with wild-type PTP1B carrying adenovirus expressed about 2-to 3-fold higher levels of PTP1B as compared to mock (Figure 6b , bottom panel). Overexpression of PTP1B significantly reduced tyrosine phosphorylation of all three STATs tested as compared to mock ( Figure 6b , upper and middle panels). To test whether PTP1B is associated with STATs, coimmunoprecipitation experiments were performed. Equal amounts of protein from VSMC that were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) were immunoprecipitated with anti-PTP1B antibodies and the immunocomplexes were analyzed by Western blotting for STATs. All three STATs were coimmunoprecipitated with anti-PTP1B antibodies suggesting their association (differential intensities of STAT bands between control vs various treatments were found to be due to lack of recognition of phosphorylated STATs by their normal antibodies) ( Figure 6c ). These results clearly suggest that NEM via inhibiting PTP1B activity caused an enhanced and sustained PDGF-BB-induced tyrosine phosphorylation of STATs.
Figure 6 PTP1B mediates NEM enhanced and sustained PDGF-BB-induced phosphorylation of STATs. (a) NEM inhibits PDGF-BB-induced PTP1B activity. Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 h and cell lysates were prepared. An equal amount of protein from control and each treatment was immunoprecipitated with anti-PTP1B antibodies and the immunocomplexes were assayed for phosphatase activity using p-nitrophenyl phosphate as a substrate. (b) Overexpression of wild-type PTP1B reverses NEM-enhanced and-sustained PDGF-BBinduced phosphorylation of STATs. VSMC were incubated for 2 h with Ad-EGFP (mock) or Ad-wt-PTP1B (wild-type PTP1B) at a multiplicity of infection (m.o.i) of 10. Virus-containing media were then removed and further culture was carried out for 48 h to allow time for the expression of transgenic proteins. VSMC were then growth arrested, treated with and without PDGF-BB (20 ng/ ml) in the presence and absence of NEM (20 mm) for 2 h and analyzed by Western blotting for tyrosine phosphorylation of STATs using their phosphospecific antibodies (upper and middle panels). PTP1B levels were measured by Western blotting using its specific antibodies (bottom panel). (c) PTP1B associates with STATs. An equal amount of protein from control and each treatment was immunoprecipitated with anti-PTP1B antibodies and the immunocomplexes were analyzed by Western blotting for STATs using their specific antibodies. *Po0.001 vs control; **Po0.001 vs PDGF-BB treatment alone
Thiol alkylation induces p21 waf1/cip1 expression and renders PDGF-BB to increase the production of active caspase 1 and cause apoptosis Earlier reports have demonstrated that activation of STATs, particularly STAT1, leads to increased expression of caspase 1 (Chin et al., 1997; Huang et al., 2000) . Since NEM inhibited PDGF-BB-induced AP-1 activity and growth in VSMC, we suspected that NEMdependent enhancement in PDGF-BB-induced STAT tyrosine phosphorylation and activation would lead to VSMC apoptosis via induction of expression of caspase 1. To test whether this is the case, growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ ml) in the presence and absence of NEM (20 mm) for 30 min, and cell lysates were prepared and analyzed by Western blotting for caspase 1 using an antibody that recognizes both the pro-and active forms. For simplicity, only the levels of caspase 1 are shown. PDGF-BB alone had no effect; however, in the presence of NEM, it increased the expression of caspase 1 threefold compared to control (Figure 7a ). NEM alone had no significant effect on the expression of caspase 1. To learn whether the increases in caspase 1 levels result in increased VSMC apoptosis, growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 6 h and apoptosis was measured by determining the cytoplasmic levels of histone-associated DNA fragments. As expected, growth-arrested VSMC exhibited a mild basal apoptotic activity and this was reversed in response to treatment with PDGF-BB (Figure 7b ). However, in the presence of NEM, PDGF-BB induced VSMC apoptosis four-fold. The finding that NEM alone, without affecting the levels of caspase 1, also stimulated VSMC apoptosis to some extent suggests that thiol alkylation triggers other events that also lead to apoptosis. A role for STAT1 in the induction of expression of p21 waf1/cip1 , a cell cycle inhibitor, has been reported previously (Chin et al., 1996; Chen et al., 2000) . To test whether thiol alkylation induces p21 waf1/cip1 expression and, thereby, paves the way for apoptosis by a mechanism independent of caspase 1, growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 5 min to 2 h and cell extracts were prepared. The p21 waf1/cip1 levels were analyzed by Western blotting. Significant amounts of p21 waf1/cip1 were observed in growth-arrested VSMC, and treatment of these cells with PDGF-BB reduced its level in a time-dependent manner, with a two-fold decrease at 2 h (Figure 8 ). Thiol alkylation alone increased the expression of p21 waf1/cip1 and, as a result, antagonized the effect of PDGF-BB on the downregulation of this cell cycle inhibitor. To confirm these observations further, we studied the effect of thiol alkylation on PDGF-BBinduced modulation of cyclin A levels, a positive regulator of the cell cycle, in VSMC. PDGF-BB increased the expression of cyclin A in growth-arrested VSMC in a time-dependent manner, with a maximum induction at 2 h, and this response was completely inhibited by thiol alkylation (Figure 8 ). Figure 7 Thiol alkylation renders PDGF-BB to induce the expression of caspase 1. (a) Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 30 min and cell lysates were prepared. Cell lysates normalized for protein were analyzed by Western blotting for caspase1 using its specific antibodies. (b) Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 6 h and apoptosis was measured by determining the cytoplasmic levels of histoneassociated DNA fragments. *Po0.01 vs control Figure 8 Effect of thiol alkylation on PDGF-BB-induced modulation of p21 waf1/cip1 and cyclin A levels in VSMC. Growtharrested VSMC were treated with and without PDGF-BB (20 ng/ ml) in the presence and absence of NEM (20 mm) for the indicated times and cell lysates were prepared. Cell lysates normalized for protein were analyzed by Western blotting for p21 waf1/cip1 or cyclin A levels using their specific antibodies
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Thiol alkylation induces p53 activity
Although activation of STAT1 correlates with p21 waf1/cip1 induction in NEM-exposed, PDGF-BB-treated VSMC, such a scenario appears unlikely in the case of PDGF-BB treatment alone. A large body of data indicates that p53 plays a determinant role in the transcriptional regulation of p21 waf1/cip1 in response to various genotoxic agents (El-Deiry et al., 1993; Levine, 1997) . Therefore, to understand the role of p53 in the modulation of p21 waf1/cip1 by PDGF-BB, we next studied the effect of PDGF-BB on p53 activity in the presence and absence of thiol alkylation. Equal amounts of nuclear protein isolated from VSMC that were treated with PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 1-2 h, or left untreated, were assayed for p53-DNA binding activity by EMSA using [ 32 P]-labeled p53 consensus oligonucleotide probe. PDGF-BB decreased p53-DNA binding activity in a time-dependent manner ( Figure 9a ). Thiol alkylation, on the other hand, by alone inducing p53-DNA binding activity, reversed the PDGF-BB-induced decreases. To confirm these results, VSMC were transfected with a p53 promoter-dependent luciferase reporter gene plasmid, p21WWW-Luc, growth arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 h and cell extracts were prepared. Cell extracts from control and each treatment were assayed for luciferase activity. PDGF-BB, although it downregulated p53-DNA binding activity, had no significant effect on p53 promoter-dependent luciferase activity (Figure 9b ). This could be due to the presence of binding sites for other transcriptional factors, such as STAT1, in the p21 waf1/cip1 promoter used (Chen et al., 2000) . Without an effect on its transcription, the decreases in p21 waf1/cip1 levels in PDGF-BB-treated VSMC may be mediated via its ubiquitination and degradation. Consistent with its effect on p53-DNA binding activity, thiol alkylation alone increased p53 promoter-dependent luciferase activity. Increased p53 promoter-dependent luciferase activity was also observed in the presence of both PDGF-BB and NEM.
Dominant negative mutants of STAT1 and p53 prevent thiol-alkylation-induced increases in the levels of caspase 1 and p21 waf1/cip1
To define further the role of STATs and p53 in PDGF-BB-induced modulation of caspase 1 and p21 waf1/cip1 levels in the presence and absence of thiol alkylation, a dominant negative mutant approach was used. VSMC that were transfected with expression plasmids for dominant negative STAT1 (Wu and Bradshaw, 2000) or p53 mutants (El-Deiry et al., 1993) were growth arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times, and cell extracts prepared. Cell extracts were analyzed by Western blotting for levels of caspase 1 and p21 waf1/cip1 . Forced expression of dominant negative STAT1 significantly reversed thiol-alkylation-dependent PDGF-BB-induced expression of caspase 1 (Figure   10a ). Both the dominant negative mutants of STAT1 and p53 significantly reversed the changes in levels of p21 waf1/cip1 induced by PDGF-BB or thiol alkylation, alone or in concert (Figure 10b ).
Discussion
Fos and Jun family proteins and their derivative transcription factor, AP-1, play an important role in the regulation of cell growth (Shaulian and Karin, 2001) . It was reported that AP-1 undergoes redox regulation in response to various stimulants (Meyer et al., 1993; Handel et al., 1995) . The findings that oxidants induce the expression of the Fos and Jun Figure 9 Thiol alkylation reverses PDGF-BB-induced downregulation of p53 activity. (a) Growth-arrested VSMC were treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times and nuclear extracts were prepared. A total of 5 mg of nuclear protein from control and each treatment was incubated with 100 000 c.p.m. of [ 32 P]-labeled p53 consensus oligonucleotide probe and the protein-DNA complexes were separated by electrophoresis on polyacrylamide gel. (b) VSMC that were transfected with a p53 promoter-dependent reporter plasmid, p21WWW-Luc, were growth arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 2 h and cell lysates were prepared. Cell lysates normalized for protein were assayed for luciferase activity. *Po0.01 vs control.
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family proteins and activate AP-1 in various cell types further support the role of redox mechanisms in the regulation of AP-1 activity (Rao et al., 1993a (Rao et al., , b, 1996 (Rao et al., , 1999 Shaulian and Karin, 2001) . Several studies have also reported that thioredoxin and glutaredoxin, thiolredox regulating proteins, modulate the activities of many transcription factors including AP-1, NFkB and CREBs Wei et al., 2000) . Furthermore, depletion of glutathione, a major intracellular thiol donor, also led to the inhibition of growth in various cancer cell types (Coffey et al., 2000; Schnelldorfer et al., 2000) . In line with these observations, the present study demonstrates that thiol blockade by NEM prevents PDGF-BB-induced expression of the Fos and Jun family proteins, AP-1 activity and growth in VSMC. Based on all these findings, it is likely that protein and nonprotein cellular sulfhydryl groups are potential sites of action for redox regulation of gene expression and growth by oxidants and mitogens.
Earlier studies from several laboratories, including ours, have reported that oxidants stimulate tyrosine phosphorylation of both RTKs and NRTKs in various cell types (Guyton et al., 1996; Knebel et al., 1996; Rao, 1996; Qin et al., 2000) . It was also reported that growthfactor-induced protein tyrosine phosphorylation requires oxidants (Sundaresan et al., 1995; Bae et al., 1997) . In this regard, it is important to note that reversible oxidation of conserved cysteinyl residues in the catalytic domain of PTP1B occurs in response to growth factors and this effect depends on oxidant production (Lee et al., 1998; Mahadev et al., 2001) . Oxidation of conserved cysteinyl residues in the catalytic domains of PTPases leads to inhibition of their activity (Denu and Dixon, 1998) . The present findings demonstrate that blockade of thiol groups enhances the PDGF-BB-induced tyrosine phosphorylation of PDGFRb and the Jak-STAT pathway proteins. A possible mechanism by which NEM can mediate increased agonist-induced protein tyrosine phosphorylation is by alkylation of conserved cysteinyl residues in the catalytic domains of PTPases, thereby inhibiting their activity. The following observations support this view: (1) PTP1B was associated with all three STATs tested. (2) PDGF-BB stimulated PTP1B activity at 2 h, a time point at which the PDGF-BB-induced STAT phosphorylation returned to basal levels. (3) NEM alkylated PTP1B and inhibited its activity induced by PDGF-BB, thereby causing an enhanced and sustained PDGF-BB-induced phosphorylation of STATs. (4) Overexpression of wild-type PTP1B substantially reversed the enhanced and sustained effect of NEM on PDGF-BB-induced phosphorylation of STATs. Thus, the enhancement in PDGF-BB-induced tyrosine phosphorylation of STATs by NEM appears to be due to thiol alkylation and inhibition of PTP1B activity. In this context, it is interesting to note that Jaks, in particular Jak2 and Tyk2, have been recently reported as substrates for PTP1B (Myers et al., 2001) . In light of these findings, a role for Jaks in NEM-enhanced andsustained PDGF-BB-induced phosphorylation of STATs via PTP1B inhibition is also possible. The association of PTP1B with STATs and the time course of an increase in its activity along with the dephosphorylation of STATs in response to PDGF-BB further points out that PTP1B is a physiological regulator of these transcription factors. The other mechanism by which NEM can enhance and sustain PDGF-BBstimulated tyrosine phosphorylation of PDGFRb, Jaks and STATs is via inhibition of ubiquitin-proteasome activity as cysteinyl residues were reported to be critical for the trypsin-like catalytic activity of the proteasome (Dick et al., 1992) . Indeed, several studies have shown that downregulation of tyrosine phosphorylated and activated RTKs such as erythropoietin receptor, NRTKs such as Jak2, and c-Ab1 and transcription factors such as STAT5 is mediated by ubiquitin-proteasome (Verdier et al., 2000; Wang et al., 2000; Echarri and Pendergast, 2001; Ungureanu et al., 2002) .
Despite enhanced tyrosine phosphorylation of its receptor and of the Jak-STAT pathway proteins, PDGF-BB, in the presence of thiol alkylation, induced waf1/cip1 . VSMC were transfected with and without expression plasmids for dominant negative mutants of STAT1 (pFSlDM) or p53 (p53R175H), growth arrested, treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times and cell lysates were prepared. Cell lysates normalized for protein were analyzed by Western blotting for caspase 1 (a) and p21 waf1/cip1 (b) using their specific antibodies Sustained activation of STATs causes apoptosis in VSMC M Bhanoori et al apoptosis instead of growth. It is possible that global blockade of thiols may inhibit various PTPase activities, and that this in turn may tip the balance between activities of PTPases and protein tyrosine kinases (PTKs) towards increased tyrosine phosphorylation and activation of several signal transduction molecules of the apoptotic and mitogenic pathways. Under such circumstances, the final response of the cell may depend on the prevalence of activation of PTKs of both the mitogenic and apoptotic pathways. This is also the likely explanation for the findings that although oxidants mimic growth factors in the stimulation of tyrosine phosphorylation of several molecules including RTKs and NRTKs and activation of transcription factors such as AP-1, they often cause cell injury rather than cell growth (Guyton et al., 1996; Knebel et al., 1996; Rao, 1996) . The second possible explanation is that thiolalkylation-enhanced PDGF-BB-induced tyrosine phosphorylation of STATs may target induction of expression of a specific set of genes involved in apoptosis. In this regard, it should be noted that in the presence of NEM, there is enhanced tyrosine phosphorylation of STATs that resulted in the formation of specific STAT-DNA complexes and the induction of expression of caspase 1. It has been reported that interferon-g-induced apoptosis in A431 and HeLa cells and EGF-induced apoptosis in A431 cells is mediated by the STAT1-dependent induction of expression of caspase 1 (Chin et al., 1997) . A role for STAT1-dependent caspase 1 induction in ischemia-induced cardiomyocyte apoptosis has also been reported (Stephanou et al., 2000) . Since a dominant negative STAT1 mutant interfered with the NEM-dependent PDGF-BB-induced caspase 1 expression, it is likely that STAT1, in the presence of thiol alkylation, mediates PDGF-BB-induced apoptosis in VSMC. However, thiol alkylation alone, without having much effect on caspase 1 induction, to some extent caused apoptosis in VSMC. In light of this, it seems likely that thiol alkylation activates other signaling events that may also lead to apoptosis. Indeed, thiol alkylation induced the expression of p21 waf1/cip1 and the dominant negative mutants of STAT1 and p53 reduced this response. A role for both STAT1 and p53 has been demonstrated in the induction of expression of p21 waf1/cip1 in many cell types (El-Deiry et al., 1993; Chin et al., 1996; Levine, 1997; Chen et al., 2000; Stephanou et al., 2000) . In addition to p21 waf1/cip1 upregulation, thiol alkylation induced activation of caspase 3 (Yellaturu et al., 2002) . Thus, NEM-induced apoptosis in VSMC may be due to cumulative involvement of several signaling events including downregulation of Akt, and AP-1 and upregulation of p53, STATs, and FKHR-L1 activities. In the case of PDGF-BB, although it activated STAT1, this response did not result in p21 waf1/cip1 expression. In fact, PDGF-BB reduced the levels p21 waf1/cip1 in VSMC. This could be due to the fact that PDGF-BB reduced p53 activity, thereby decreasing p21 waf1/cip1 transcript levels and enabling cells to progress through the cell cycle. The decreased p53 activity may be setting off the influence of STAT1 on p21 waf1/cip1 induction in PDGF-BB-treated VSMC.
It has been well accepted now that oxidants act as second messengers in the signal transduction pathways of proliferation and apoptosis (Meier et al., 1989; Rao and Berk, 1992; Schmidt et al., 1996; Sen and Packer, 1996; Sun and Oberley, 1996; Bae et al., 1997; Rao et al., 1999; Li et al., 2000; Hoshi and Heinemann, 2001; Lee et al., 2001; Preston et al., 2001) . In addition, oxidants were reported to stimulate growth in some cell types, whereas in others they caused apoptosis (Rao and Berk, 1992; Li et al., 2000; Lee et al., 2001; Preston et al., 2001) . These dual effects of oxidants appear to depend on the ability of the target cell to respond to oxidant injury: cells with weak ROS scavenging mechanisms may undergo apoptosis, whereas cells with sufficient ROS scavenging mechanisms may resist oxidant stress and, as a protective response to oxidant injury, may undergo proliferation (Rao and Berk, 1992; Li et al., 2000) . Although both the mitogens and the inducers of apoptosis stimulate acute production of oxidants and require an oxidant state to accomplish the respective cellular response (Rao et al., 1999; Gottlieb et al., 2000) , the functional specificity of oxidants may be achieved by the spatial and temporal pattern in their production in response to a specific agonist. Since oxidation/reduction of conserved cysteinyl residues in the catalytic domains of PTPases is an important factor in the regulation of their activity, and since PTPases play an important role in signaling events (Denu and Dixon, 1998; Chernoff, 1999) , these cysteinyl residues could be the potential targets for agonist-induced oxidant action in the propagation of mitogenic or apoptotic signals. The present findings offer support for the role of cellular thiols in the signal transduction pathways of both cell proliferation and apoptosis and show that a sustained change in the thiol redox state can influence a mitogen to stimulate proapoptotic signaling events in VSMC.
Materials and methods
Reagents
Aprotinin, NEM, phenylmethylsulfonyl fluoride (PMSF), pnitrophenyl phosphate, sodium orthovanadate, sodium deoxycholate, leupeptin, HEPES and dithiothreitol were purchased waf1/cip1 (HZ52) antibodies were bought from Neomarkers (Fremont, CA, USA). Anti-PTP1B antibodies (P-18020) were obtained from Transduction Laboratories (San Diego, CA, USA). T4 polynucleotide kinase was procured from GIBCO BRL (Grand Island, NY, USA). Adeno-X kit was from Clontech (Palo Alto, CA, USA). Cell death detection ELISA and MTT cell proliferation kits, and FuGENE 6 transfection reagent were obtained from Roche Molecular Biochemicals (Indianapolis, IN, USA Cell Culture VSMC were isolated from the thoracic aortae of 200-300 g male Sprague-Dawley rats by enzymatic dissociation as described earlier (Rao et al., 1995) . Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin. Cultures were maintained at 371C in a humidified 95% air and 5% CO 2 atmosphere. Cells were growth arrested by incubating in DMEM containing 0.1% (v/v) FBS for 72 h and used to perform the experiments unless otherwise stated.
Cell death assay
This assay is based on a quantitative sandwich-enzymeimmunoassay using mouse monoclonal antibodies directed against DNA and histones. Cells were seeded onto a 24-well tissue culture plate at a density of 8 Â 10 3 cells/well in 2 ml of DMEM containing 10% FBS and grown in a humidified incubator (95% air-5% CO 2 ) at 371C. At about 80% confluence, cells were growth arrested by incubating in DMEM with 0.1% FBS for 72 h. Growth-arrested cells were then treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 6 h. After treatments, cell extracts were prepared and histone-associated DNA fragments in the cytosolic fraction of the cell lysates were measured using a commercial kit following the manufacturer's protocol (Roche Molecular Biochemicals) at 405 nm in a Spectra Max 190 microtiter plate reader (Molecular Devices Inc., Sunnyvale, CA, USA).
Cell growth assay
Cell growth was measured using a kit from Roche Molecular Biochemicals (Indianapolis, IN, USA). Cells were plated onto a 96-well tissue culture plate at a density of 2 Â 10 3 cells/well in 100 ml of DMEM containing 10% FBS and grown in a humidified incubator (95% air-5% CO 2 ) at 371C. At about 80% confluence, cells were growth arrested by incubating in DMEM with 0.1% FBS for 72 h. Growth-arrested cells were then treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for 24 h. After treatments, 10 ml of 0.5 mg/ml MTT labeling reagent in PBS was added to each well and cells were incubated in a humidified incubator (95% air-5% CO 2 ) at 371C for 4 h. A total of 100 ml of solubilization solution (10% SDS in 0.01 m HCl) was then added and incubation continued overnight. Formazan, a dark blue product formed by the cleavage of MTT by living cells, was measured at 570 nm in a Spectra Max 190 microtiter plate reader (Molecular Devices Inc., Sunnyvale, CA, USA).
Electrophoretic mobility shift assay
Nuclear extracts were prepared from treated or untreated VSMC according to the procedure described by Dignam et al. (1983) . The protein content of the nuclear extracts was determined using Micro BCAt Protein Assay Reagent Kit (PIERCE, Rockford, IL, USA). Protein-DNA complexes were formed by incubating 5 mg of nuclear protein in a total volume of 20 ml consisting of 15 mm HEPES, pH 7.9, 3 mm TrisHCl, pH 7.9, 60 mm KCl, 1 mm EDTA, 1 mm PMSF, 1 mm dithiothreitol, 4.5 mg of bovine serum albumin (BSA), 2 mg of poly (dl-dC), 15% glycerol and 100 000 cpm of [ 32 P]-labeled oligonucleotide probe for 30 min on ice. The protein-DNA complexes were then resolved by electrophoresis on a 4% polyacrylamide gel using 1 Â Tris-glycine-EDTA buffer (25 mm Tris-HCl, pH 8.5, 200 mm glycine, 0.1 mm EDTA). Double-stranded oligonucleotides were labeled with [g 32 P]-ATP using the T4 polynucleotide kinase kit (GIBCO-BRL) following the supplier's protocol.
PTP1B assay
After appropriate treatments, VSMC were lysed in a lysis buffer consisting of 25 mm HEPES, pH 7.2, 150 mm NaCl, 5 mm DTT, 2.5 mm EDTA, 1% Triton X-100, 2 mm leupeptin, 100 U/ml aprotinin and 400 mm PMSF. Cell lysates consisting of 500 mg protein from control and each treatment were immunoprecipitated with 3 mg of monoclonal PTP1B antibodies overnight at 41C, at which time 40 ml of 50% (w/v) protein A-sepharose CL-4B beads was added and incubation continued for another 2 h. Immunoprecipitates were washed three times with lysis buffer and resuspended in 25 ml of assay buffer (25 mm HEPES, pH 7.2, 50 mm NaCl, 5 mm DTT and 2.5 mm EDTA). The reaction was initiated by the addition of 50 ml of 50 mm p-nitrophenyl phosphate and 10 ml of 2 mg/ml BSA and incubating at 371C for 20 min. The reaction was then terminated by the addition of 50 ml of 4 m Na 2 CO 3 . The reaction mixture was spun down and the absorbance of the supernatant was measured at 405 nm in a Spectra Max 190 microtiter plate reader (Molecular Devices Inc., Sunny vale, CA, USA). Phosphatase activity was calculated using a molar extinction coefficient value of 1.78 Â 10 4 for p-nitrophenyl phosphate at 405 nm.
PTP1B thiol alkylation
Growth-arrested VSMC were incubated with [ 3 H]-NEM (60 mCi/ml, S.A. 50 Ci/mmol) and 10 mm cold NEM in the presence and absence of 20 mm NAC for 2 h at 371C. After incubation, cells were lysed in 300 ml of lysis buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 100 mg/ ml PMSF, 100 mg/ml aprotinin, 1 mg/ml leupeptin and 1 mm sodium orthovanadate) on ice for 30 min. Cell lysates containing 500 mg of protein from each treatment were then incubated with 3 mg of monoclonal PTP1B antibodies at 41C overnight, at which time 50 ml of 50% (w/v) protein A-sepharose CL-4B beads were added and incubation continued for an additional 2 h. Immunocomplexes were washed three times with lysis buffer and the radioactivity in the immunocomplexes was measured in a liquid scintillation counter (Beckman model LS 5000TA).
Preparation of recombinant adenovirus expressing wild-type PTP1B protein
Replication-deficient (E-1 deleted) recombinant adenovirus expressing wild-type PTP1B was prepared via the use of a commercial kit (Adeno-X). The cDNA for PTP1B (in the plasmid, pJ3H-PTP435, containing wild-type human sequence PTP1B) was flanked at the N-terminus by a single hemagglutinin (HA) epitope. This construct was used as a template to amplify PCR products expressing the corresponding fulllength cDNA for PTP1B (including the HA epitope), flanked by Not I and Kpn I restriction sites. PCR products were then subcloned into the Not I/Kpn I site of pShuttle vector provided by the Adeno-X kit. All sequences of PTP1B inserts in pShuttle were verified by nucleotide sequencing and conformed to published sequences (Chernoff et al., 1990 ). An ICeu I/PI-Sce I fragment from pShuttle containing the CMV-IE promoter/enhancer 5 0 to the cDNA insert and the bovine growth hormone poly adenylation signal 3 0 to the insert was ligated into adenoviral DNA backbone that was also restricted with I-Ceu I and PI-Sce I. Following amplification and purification of recombinant viral DNA from bacteria, adenovirus was produced by transfecting Pac 1-linearized recombinant viral DNA into HEK 293 cells via the use of the lipid transfection agent FuGENE 6. Adenoviral titers were determined via a standard procedure by measurement of their cytopathic effect in HEK 293 cells. For control experiments, adenovirus expressing enhanced green fluorescence protein (EGFP) was prepared in a similar manner.
Thiol determination
After appropriate treatments, thiols in VSMC were determined according to the method of Ellman, using DTNB (Ellman, 1959) .
Transient transfection and reporter gene assay
VSMC were plated evenly onto 60 mm dishes the day before transfection and grown in DMEM containing 10% (v/v) heatinactivated FBS, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were transfected with appropriate plasmid DNA (20 mg/60 mm dish) using either calcium phosphate precipitation or FuGENE 6 transfection reagent as described previously (Rao et al., 1999; Ghosh et al., 2002) . Cells were washed with phosphate-buffered saline (PBS) 16 h after transfection and incubated in DMEM containing 0.1% (v/v) FBS for 36 h at 371C. Cells were then treated with and without PDGF-BB (20 ng/ml) in the presence and absence of NEM (20 mm) for the indicated times and cell lysates were prepared. An equal amount of cell lysate protein was assayed for CAT activity, using [
14 C]-chloramphenicol and acetyl coenzyme A as substrates, or for levels of caspase 1 and p21 waf1/cip1 Lucjferase activity was measured using Luciferase Assay System (Promega) and Turner Luminometer .
Western blot analysis
After appropriate treatments, VSMC were rinsed with cold PBS and frozen immediately in liquid nitrogen. Cells were lysed by thawing in 250 ml of lysis buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 100 mg/ml PMSF, 100 mg/ml aprotinin, 1 mg/ml leupeptin and 1 mm sodium orthovanadate) and scraped into 1.5 ml Eppendorf tubes. After standing on ice for 20 min the cell lysates were cleared by centrifugation at 12 000 r.p.m. for 15 min at 41C. Cell lysates containing equal amount of protein were resolved by electrophoresis on 0.1% SDS and 10% polyacrylamide gels. The proteins were transferred electrophoretically to a nitrocellulose membrane (Hybond, Amersham Pharmacia Biotech, Piscataway, NJ, USA). After blocking in 10 mm Tris-HCl buffer, pH 8.0, containing 150 mm sodium chloride, 0.1% Tween 20 and 5% (w/v) nonfat dry milk, the membrane was treated with appropriate primary antibodies followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies. The antigen-antibody complexes were detected using a chemiluminescence reageant kit (Amersham Pharmacia Biotech).
Statistics
All experiments were repeated at least three times with a similar pattern of results. Data on cell proliferation, apoptosis and PTP1B assays are presented as mean7s.d. Treatment effects were analyzed by Student's t-test. P values o0.05 were considered to be statistically significant. In the case of Western blot analysis, EMSA and transfection assays, one representative set of data is shown.
